Communicate with Supplier? Supplier
Kelly Ms. Kelly
What can I do for you?
Chat Now
Chat Now Contact Supplier

 Shandong Haohong Biotechnology Co., Ltd.

  • All
  • Title
  • All
  • Title
HomeProductsActive Pharmaceutical Ingredient(API)Cabozantinib APICabozantinib API Cas 849217-68-1

Cabozantinib API Cas 849217-68-1

Payment Type:
L/C,T/T,Western Union
Min. Order:
1 Kilogram
Delivery Time:
3 Days
Chat Now
  • Product Description
Product Attributes

Model No.CAS 849217-68-1


place of originChina

Types ofPharmaceutical Intermediates

Phasical StateSolid Powder

CAS No.849217-68-1

ColorWhite To Off White

Molecular FormulaC28H24FN3O5

Molecular Weigh501.50600



Density1.397 G/cm3

Boiling Point758.075ºC At 760 MmHg

Flash Point412.269ºC

Supply Ability & Additional Informations

PackagingPE BAG+Aluminum foil bag+FIBRE DRUM




Supply Ability60KG/MONTH

HS Code2933499090


Payment TypeL/C,T/T,Western Union


Delivery Time3 Days

Packaging & Delivery
Selling Units:
Package Type:
PE BAG+Aluminum foil bag+FIBRE DRUM

Product Name:





cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide;


API name: CABOZANTINIB Intermediate CAS No.: 849217-68-1

Cabozantinib, marketed under the trade name Cabometyx among others, is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis. It was discovered and developed by Exelixis Inc.

Cabozantinib was granted orphan drug status by the U.S. Food and Drug Administration (FDA) in January 2011. Cabozantinib is approved by the U.S. FDA for medullary thyroid cancer. and advanced renal cell carcinoma in people who have received prior anti-angiogenic therapy. It is currently undergoing clinical trials for the treatment of prostate, bladder, ovarian, brain, melanoma, breast, non-small cell lung, pancreatic, and hepatocellular cancers.

We, Shandong Haohong Biotechnology Co., Ltd. are manufacture of API and intermediates,Cabozantinib is our top strong project.

We can offer best quality product with perfect service, full documents support, factory audit is availbale.

Purity HPLC:> 99%

Water contents :< 0.30%

Packing and Storage: Preserve in well-closed containers, and store at room temperature.

Capacity: 200mt/year

Cabozantinib Cas 849217-68-1

Our Cabozantinib Intermediate list is as following, we have all the below intermedites offering all year.


Cabozantinib APICabozantinib Cas 849217-68-1;Cabozantinib Cas No 1140909-48-3

Cabozantinib IntermediatesCabozantinib Cas 35654-56-9Cabozantinib Cas 13425-93-9Cabozantinib Cas 598-10-7

Cabozantinib Cas 190728-25-7;Cabozantinib Cas:3697-66-3;Cabozantinib Cas:849217-48-7

Package & Shipping:

1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping for 100KG above; Sea shipping for quantity over 500KG.
2. We can offer complete package from concept to delivery; arranging everything up until products arrive at your own door or distribution hub.


Our Service:

1. Supply high quality products with reasonable prices for pharmaceutical factory.
2. In time delivery, Packing pictures and loading video before loading.
3. Various documents(COA, MSDS, ROS, MOA etc.) and factory audit available.
4. Pre-sale consultation and post-sale service available.
5. Provide market informations to make customers fully informed.

Product Categories : Active Pharmaceutical Ingredient(API) > Cabozantinib API

Company Overview
Shandong Haohong Biotechnology Co., Ltd. is located in Provincial Chemical Industrial Park of Liaocheng city, Shandong province, which is a beautiful water city. The total production area is around 130 thousand square meters, with 40 employees and 12 R&D technicians. Our company focuses on the development and production of pharmaceutical products, with 13 sets of 50L to 5000L reactors, and the annual manufacturing capacity can up to 500 tons. We had advanced sewage treatment system, with the daily processing capacity of 1000 tons. The new R&D laboratory is located on the 4th floor of the accelerator middle section of Qilu Science and Technology Town, Qilu High-tech Development Zone, Shandong Province, and is located in a large modern ecological science and technology park in Qihe Science and Technology City of Zhongguancun Haidian Park. Our company mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, tofacitinib citrate, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized, and at the same time, we can provide customers with efficient customized synthesis services from grams to 100 kilograms. We will continue to provide high quality products with most competitive prices and good service to customers all over the world. We sincerely hope to establish stable and strategic business relationships with customers from home and abroad.
Company Photos
Production Certification
Email to this supplier
  • *To:
    Ms. Kelly
  • *Message:
    Your message must be between 20-8000 characters




About Us